A new publication on icatibant, an approved compound, was released on September 30, 2026. The paper, titled "Development and validation of an RP-HPLC method for the quantification of impurities of icatibant injection in finished formulations-identification and characterization of its impurities via LC-HRMS," appears in the European Journal of Mass Spectrometry (Chichester, England).
The publication describes work on developing and validating an RP-HPLC method intended for quantifying impurities found in icatibant injection finished formulations. It also references the identification and characterization of these impurities using LC-HRMS techniques.
This brief reports only the existence and title of this publication as recorded in the source data. No findings, results, or conclusions from the study are summarized here, as that information was not provided in the event data. Readers interested in the specific methodology or any reported outcomes should consult the original publication directly through the journal.
For general background on icatibant, including its approved uses and regulatory status, readers can refer to the compound overview.